Bronchodilatory effect of Myxopyrum serratulum in animal model
Abstract
The plant Myxopyrum serratulum is traditionally claimed to relieve asthma and cough. The present study was undertaken to evaluate the bronchodilatory effect of the methanolic extract of M. serratulum on histamine-induced bronchospasm by in vivo and the inhibitory effect of the extract on histamine-contracted tracheal chain and ileum by in vitro guinea pig model. Additionally, the relaxant effect of four cumulative concentrations of the extract (0.25, 0.5, 0.7 and 1.0 g%) was assessed using precontracted tracheal chain under different conditions. The extract (400 mg/kg) prolonged the preconvulsive time to 102.3 ± 3.8 sec when compared to saline and standard chlorpheniramine maleate as 121.3 ± 4.5 sec (p<0.05). The extract also possessed significant inhibitory effect on histamine-contracted guinea pig ileum and tracheal chain and also exhibited significant relaxation effect on precontracted tracheal chain of guinea pig models contracted by 60 mM KCl (p<0.001) and 10 µM methacholine (p<0.001) when compared with standard theophylline.
Introduction
Bronchial asthma is a chronic inflammatory disease of the airway. Infiltration of various inflammatory cells such as eosinophil, macrophages and lymphocytes into the airway causes asthma and bronchitis (Patel et al., 2013).
Bronchodilator drugs works by rapid reversal of the airway obstruction in asthmatics by directly acting on airway smooth muscle (Church and Hiroi, 1987). Drugs derived from natural sources are generally considered no adverse effects when compared to synthetic drugs, therefore, it might serve as better alternative for many chronic diseases such as cancer, infections and endemic diseases like asthma, bronchitis and many others (WHO, 2000). Plant extract and secondary metabolites derived from plant can directly influence the production and activation of inflammatory mediators, secondary messengers and the expression of transcription factors (Calixto et al., 2004).
Myxopyrum serratulum belongs to large shrub mainly found in Kerala at a altitude of about 600-900 m. It is commonly known as chaturamulla and traditionally, dried and powdered leaves of the plant was mixed with ghee as a remedy for asthma, cough and nerves complaints apart from which they were also used for the treatment of fever, headache and ear diseases (Wealth of India, 2011).
According to earlier reports, the plant possesses anti-inflammatory, antiarthritic (Sheelarani et al., 2013), antioxidant (Sheelarani et al., 2013), antipyretic (Vanughese et al., 2015), wound healing (Gopalakrishnan and Rajameena, 2013) and antimicrobial (Gopalakrishnan et al., 2012) properties.
The phytochemical studies on M. serratulum revealed the presence of flavonoids, saponins, terpenoids, carbohydrates, ursolic acid (Sudharmini and Ashalatha, 2008) and myxopyroside, its 6-o-acetyl-7-o-(E/Z)-p-methoxycinnamoyl esters (2/3) of dimethyl forsythide (Franzyk et al., 2001). There was no scientific report found regarding the bronchodilatory activity of M. serratulum though it has been used for allergy and inflammation. Hence, the present study was mainly focused on the evaluation of its bronchodilatory activity both in vivo and in vitro guinea pig model.
Materials and Methods
Plant collection and extract preparation
The leaves of M. serratulum were collected from the Western Ghats of Kerala, India in the month of September 2013, and identified by Dr. V. Chelladurai, Government Siddha Medical College, Palayamkottai, Tamilnadu, India. A voucher specimen (MS-0713/BIT) of the leaves were preserved and stored at the Department of Pharmaceutical Technology, Anna University, Tiruchirappalli, India. The dried leaves were coarsely powdered and then extracted with methanol by hot extraction method. The extract was concentrated under reduced pressure and finally viscous and dense dark green color extract was obtained with yield percentage of 22.2% w/w and stored at 4°C for further studies.
Chemicals
Histamine, methacholine, chlorpheniramine maleate, propranolol hydrochloride and theophylline were procured from the Sigma-Aldrich (Germany). All the chemicals and solvent used for the preparation of physiological salt solution and extract preparation were of analytical grade and were obtained from the Merck, Germany. Ultrapure water was used for the experiments.
Animals
Male Hartley strain guinea-pigs of 300-400 g weight and female Balb/c mice weighing 25-30 g were housed at animal house of the Bharathidasan Institute of Technology, Anna University, Tiruchirappalli, India. All the experimental animals were maintained in standard conditions with room temperature of 23-25°C and humidity of 50-60%. All the animals were given clean water ad libitum and standard food.
Acute toxicity test
Female Balb/c mice weighing 25-30 g were divided into 5 groups comprising of 5 mice each. The test was performed using various doses of the extract (10, 50, 300 and 2,000 mg/kg) at 10 mL/kg volume were administered orally. Another group of mice that received saline (10 mL/kg, p.o.) alone was considered as negative control. All the experimental mice models were maintained in a standard condition as mentioned above and were periodically observed for physiological parameters that includes mortality, morbidity, salivation, diarrhea, convulsions, tremors, lachrymal secretion, hair erection and loss of appetite.
In vivo bronchodilating activity
Experimentally, bronchial asthma was induced by exposing the guinea pigs to 0.5% histamine aerosol using an ultrasound nebulizer in aerosol chamber (24 x 14 x 24 cm3) made of perspex glass. The time required for the appearance of preconvulsive dyspnoea caused by histamine was noted for each animal. The pre-convulsion time i.e. the duration of aerosol exposure for the onset of respiratory distress leading to appearance of convulsion was noted (Liu et al., 2015). The animals were removed from the perspex container and allowed to recover from the respiratory distress by exposing to fresh air for 24 hours. After 24 hours, the animals were grouped into five (n = 6), among which the animals of Group I received oral dosage of vehicle (0.95% NaCl solution); Group II received standard chlorpheniramine maleate at a dosage of 100 mg/kg; Group III, IV and V received 100, 200 and 400 mg/kg oral dose of the extract, respectively. After the administration of the vehicle, standard and test drugs, the pre-convulsion time was reassessed after 1st and 4th hours, and the percentage increase in pre-convulsion time was calculated as per the prescribed formula (Sheth et al., 1972).
Guinea-pig ileum preparation
The ileum was dissected out and segments of approximately 2 cm length were kept individually in a 10 mL organ bath filled with Tyrode's solution and aerated with oxygen at 37°C. A preload of 1 g tension was applied to each tissue and kept constant throughout the experiment. Following an equilibration period of 30 min, isotonic contractions to histamine (1 - 32 µM) were repeated until constant responses were obtained. The inhibitory effect of the extract (100 µg/mL) and chlorpheniramine (10 µg/mL) was determined on the resting baseline of the tissue and was assessed as percentage of the maximum effect produced by histamine (Choo and Mitchelson, 1978).
Tracheal chain preparation
Male Hartley guinea pigs (300-400 g) were killed by imposing a blow on the neck followed by the removal of tracheas. Each trachea was cut into 10 rings (each containing 2-3 cartilaginous rings). The cartilages of all rings were then cut open opposite to the tracheal muscle and sutured together to form a tracheal chain (Martin et al., 1994). The tracheal chain was then suspended in a 10 mL organ bath containing Krebs-Henseliet solution of the following composition (mM): NaCl 120, NaHCO3 25, MgSO4 0.5, KH2PO4 1.2, KCl 4.7, CaCl2 2.5 and dextrose 11. The Krebs solution was kept at 37°C under stream of 95% O2 and 5% CO2 gases. Tissue was suspended under an isotonic tension of 1 g and allowed to equilibrate for at least 1 hour while it was washed with Krebs solution every 15 min.
Protocols
The inhibitory effect of the extract on histamine H1-receptors was examined by producing a cumulative log concentration-response curve of histamine-induced contraction of tracheal chains 10 min after exposing tissue to extract (100 µg/mL) and 0.3 mL saline. The consecutive concentrations of histamine were added every 2 min (1 - 32 µM) and the percentage of contraction, due to each concentration in proportion to the maximum contraction obtained in the presence of saline, was plotted against the log concentration of histamine (Boskabady and Shaikhi, 2000).
In addition, the relaxant effects of four cumulative concentrations of the extract (0.25, 0.5, 0.75 and 1.0 g/100 mL), four cumulative concentrations of theophylline (0.25, 0.5, 0.75 and 1.0 mM; positive control) and saline (1.0 mL; negative control) were also examined. The above mentioned agents of specified volumes were added to 10 mL organ bath and the contracted tracheal tissues were incubated into the bath for 5 min. The post incubation, effect of the extract, theophylline and saline at different concentrations were determined. A decrease in tone was considered as relaxant (bronchodilatory) effect and expressed as positive percentage change in proportion to the maximum contraction, whereas, an increase in tone was considered as contractile (bronchoconstrictory) effect, expressed as negative percentage change (Holroyde, 1986). The relaxant effect of the extract, standard and control were evaluated with three different experimental designs as follows: a) On tracheal chains contracted by 60 mM KCl (Group I experiments); b) On non-incubated tracheal chains contracted by 10 uM methacholine hydrochloride (Group II experiments); c) On tracheal chains incubated with 1 uM propranolol hydrochloride for 30 min prior to beginning and during the evaluation of relaxation effect of different solutions. In this series of experiments tracheal chains were also contracted by 10 uM methacholine hydrochloride (Group III experiments).
The relaxant effect of theophylline was examined only on Groups I and II. Separate tracheal chains were used for all the experiments. In all experiments, responses were recorded on a kymograph and were measured after fixation. The data were expressed as mean ± standard error of the mean (SEM., n = number of experiments) and one-way analysis of variance (ANOVA) followed by Dunnett's test. p<0.05 is considered as significant.
Results
Acute toxicity study
It was observed that even after 14 days post administration of 2 g/kg of extract, the experimental animals did not exhibit mortality, which rules out any possibility of toxicity in the M. serratulum.
In vivo bronchodilating activity
Chlorpheniramine (100 mg/kg) prolonged the preconvulsive time to 121.3 ± 4.6 sec and the percentage protection was 75.3 ± 4.6 (Figure 1). Similarly, the test extract was also observed to possesses bronchodilatory activity by prolonging the preconvulsive time to 59.3 ± 3.0 sec and 102.3 ± 3.9 sec at 100 mg/kg and 400 mg/kg respectively, for which the maximum percentage protection was 68.7 ± 1.6 at higher concentration. In all the groups no significant differences were observed in preconvulsive time of guinea pigs before the drug administration. The results clearly indicated that significant difference was observed in groups treated with test extract at 400 mg/kg (p<0.05) and chlorpheniramine at 100 mg/kg (p<0.05) compared to that of control (a significant increase in preconvulsive time was also observed when compared with the results recorded before administration of the test agents).
Figure 1: Effects of leaves of M. serratulum on the preconvulsive time of guinea pigs challenged with the solution of 0.5% histamine Values are expressed as mean S.E.M. (n=6), p< 0.05, compared with the data of negative control, after drug administration p<0.05 compared to before drug administration
Effect on isolated guinea pig ileum
There was inhibitory effect of the extract on histamine-induced contraction on guinea pig ileum (Figure 2). The inhibition of %response of the extract (100 µg/mL) was 19.7 ± 1.1, 33.0 ± 1.7, 41.4 ± 1.9, 42.1 ± 2.1, 58.0 ± 1.8 and 68.2 ± 1.6 at the respective concentration of 1, 2, 4, 8, 16 and 32 µg/mL of histamine when compared with the effect of chlorpheniramine (10 µg/mL) (p<0.001).
Figure 2: Log dose-response curve obtained after incubation of cumulative concentration of histamine (1 µg/mL - 32 µg/mL) in isolated guinea pig ileum preparations in the presence and absence of M. serratulum (100 µg/mL) and chlopheniramine. Values represent mean ± SEM, n = 6
Effect on isolated guinea pig trachea
The relaxant efficiency of the extract (100 µg/mL) on histamine induced pre-contracted tracheal chain were as shown in Figure 3, which clearly indicates that the plant extract (p<0.001) significantly reduced the maximum contractile response of histamine on guinea pig tracheal chain. These above findings are also clearly stated that the extract had possess a significant bronchodilatory effect through H1-receptor antagonistic activity as similar that of chlorpheniramine.
Figure 3: Log dose-response curve obtained after incubation of cumulative concentration of histamine (1 µg/mL - 32 µg/mL) in isolated guinea pig tracheal preparations in the presence and absence of M. serratulum (100 µg/mL ). Values represent mean ± SEM, n = 6
Relaxant effect on isolated guinea pig trachea
Theophylline and the extract (Group I) showed potent relaxant effect on precontracted guinea pig tracheal chain in concentration-dependant manner, and at higher concentration, the percentage maximum relaxant effect observed for extract and theophylline were 91.6 ± 3.2 and 88.7 ± 2.6 respectively. At all the concentrations, the relaxant effect of theophylline and test extract were significantly higher than those of the control group that received saline only (Table I).
Table I: Relaxant effect of extracts in tracheal chain contracted by high potassium and methacholine
| Concentration of extract | High K+ | Methacholine | Propranolol and methacholine | ||
|---|---|---|---|---|---|
| Extract | Theophylline | Extract | Theophylline | Extract | |
| 0.25 | 19.9 ± 2.1 | 12.3 ± 1.1 | 14.6 ± 1.1 | 11.5 ± 1.1 | 5.6 ± 1.2 |
| 0.5 | 32.4 ± 1.9 | 25.0 ± 1.9 | 39.6 ± 2.9 | 29.9 ± 1.6 | 13.8 ± 2.9 |
| 0.75 | 59.3 ± 2.2 | 47.1 ± 2.6 | 60.0 ± 1.9 | 54.2 ± 1.3 | 21.5 ± 2.6 |
| 1.0 | 91.6 ± 3.2 | 88.7 ± 2.6 | 101.6 ± 2.3 | 92.2 ± 1.6 | 26.8 ± 2.9 |
Both the extract and theophylline (Group II) exhibited potent relaxant effect in the precontracted guinea pig tracheal chain with methacholine. At lower concentration, both theophylline and extract showed less relaxant effect and at higher concentrations the percentage relaxant effect was found to be 101.6 ± 2.3 and 92.2 ± 1.6 for test extract and theophylline respectively. In both Group 1 and 2 experiment, the extract exhibited potent relaxant effect in the dose dependant manner than the standard drug theophylline.
In Group III experiment, the extract of M. serratulum exhibited weak relaxant effect at all concentration when compared with saline. The relaxant effect of the extract was higher than theophylline at all concentration in Groups I and II experiments. There were positive correlations between increasing concentrations and the relaxant effects of extract in Groups I and II experiments.
Discussion
The results seem consistent with the earlier findings, that the chloroform extract of Cynodan dactylon exhibited bronchodilator effect by increasing preconvulsive time against acetylcholine induced bronchospasm in a dose-dependant manner at 5, 10, 50, 100 mg/kg but no significant protection against histamine-induced bronchospasm (Patel et al., 2013). In earlier studies, 70% ethanolic extract of Elaeagnus pungens increased preconvulsive time on combination of 0.1% histamine and 2% acetylcholine-induced bronchospasm at the dose of 1.4 g/kg after 5 days of administration (Ge et al., 2009). The protective effect of bronchodilator was demonstrated by pre-dosing of the extract, increases the pre-convulsion time after administration of spasmogenic agent, thus indicating the protective effect of the bronchodilator (Webber and Karlsson, 1996). It is evident that the H1-receptor plays a vital role in bronchospasm, the stimulation of H1-receptor by histamine produces smooth muscle contraction, increased vascular permeation and mucus secretion. The H1-receptor effects are blocked generally by antihistaminic drug. In this present study, the extract (400 mg/kg) exhibited similar protective effect as that of chlorpheniramine (100 mg/kg) against histamine induced bronchospasm. The results clearly indicates that the extract at higher dose possess H1-receptor antagonistic property similar to that of chlorpheniramine. The inhibitory effect of extract on isolated guinea pig ileum precontracted with histamine were also studied and the results clearly indicate that the phytoconstituents present in the extract exerted an antagonistic effect on H1-receptor.
The other possible mechanisms involved in the relaxant effects of the extract from M. serratulum on tracheal chains of guinea pigs could be because of its beta-adrenergic agonist property, antagonistic activity on H1 -receptors. The mechanism of beta-adrenergic agonist, increasing the activation of adenylate cyclase followed by increasing the concentration of intracellular cyclic adenosine 3', 5'-monophosphaste (cAMP), accelerates the activation of specific cAMP-dependent protein kinase that causes relaxation (Popa et al., 1984). To evaluate the beta-adrenergic stimulant effect of extract on its bronchodilatory effects, the effects of these extracts on tracheal chains inhibited with beta-receptors by propranolol were re-examined in Group III experiment. The relaxant effects of most concentrations of methanolic extract obtained in the Group III experiment were significantly lower than those of Group I and II. These findings suggest probable mechanism of bronchodilation of the plant extract might be due to beta-adrenergic stimulatory property. The potent relaxant effect of M. serratulum extract in Group I experiment (contracted tracheal chains by 60 mM KCl), the results clearly indicated that a calcium-channel blocking effect of this plant. It was also identified that the absence of an opening effect of this plant on potassium channel resulted in the bronchodilatory effect (Buckle et al 1993). If the extract had a potassium-channel opening effect, it would not have relaxant effects on KCl-contracted tracheal chains.
Other plants traditionally used for asthma such as Viola odorata (Janbaz et al., 2015) and Buxus wallichiana (Hussain et al., 2015) act by blocking Ca2+ channel. Bronchodilator activity of Urginea indica possibly mediates through a combination of anticholinergic and Ca2+ antagonist mechanism (Bashir et al., 2013).
The mechanism of bronchorelaxation of the drug theophylline, a xanthine derivative, is by inhibition of phosphodiesterase activity which leads to increased amount of intra cellular cAMP molecules causing smooth muscle relaxation, inhibition of calcium ion influx into smooth muscle (Hansel et al., 2004). The results of the above experiment suggests that the bronchodilatory activity of M. serratulum was similar/somewhat higher than that of theophylline, which might be due inhibition of calcium ion influx into smooth muscle by the plant extract. Apart from these, the M. serratulum plant extract is also found to be rich in naringenin, a predominant phenolic compound, which is known to possess excellent antiallergic property through the inhibition of iNOS and TH2 cytokine production in lung and thus reduces airway hyper-responsiveness against ovalbumin induced allergen model (Shi et al, 2009). Quercetin and rutin also found in extract at higher concentration, that are known to exhibit potent antiasthmatic effect via inhibition of the recruitment of eosinophills and neutrophils into the lung, the production of histamine, phospholipase A2 and eosinophil peroxidase (Chan Hun et al., 2007). In addition, the plant M. serratulum reported to possess the bioactive compounds: Triterpenoid, ursolic acid and iridoid glycoside myxopyroside they have several pharmacological activities including antimicrobial, antiasthmatic, antiallergic and anti-inflammatory, cardiovascular and anti-cancer effect (Wozniak et al., 2015; Kim et al., 2013). The potency of several iridoid derivatives on smooth muscle were reported (Chung et al., 1980; Breschi et al., 1992; Rojas et al., 2000) which were in support of our result.
All the data derived from the present study is in correlation with these earlier findings, that suggests that plants containing the phenolic compounds including naringenin, rutin, quercetin, triterpenoids ursolic acid and iridoid glycoside may contribute the observed bronchodilatory efficiency of the plant.
Conclusion
M. serratulum possesses significant bronchodilatory effect through the underlying mechanisms such as histamine (H1) receptor antagonistic, beta-adrenoceptor stimulatory, an inhibitory effect on calcium channels. This study serves as a scientific evidence for the ethnomedicinal uses of M. serratulum in airway diseases.
Ethical Issue
The animal study was performed according to the CPCSEA guidelines and approved by Institutional Animal Ethical Committee of Bharathidasan Institute of Technology, Anna University, Tiruchirappalli. (Ref. No: AUROT/IAEC/NOV2013-0025 dt.21/11/2013).
References
Bashir S, Abbas S, Khan A, Gilani A. Studies on bronchodilator and cardiac stimulant activities of Urginea indica. Bangladesh J Pharmacol. 2013; 8: 249-54.
Boskabady MH, Shaikhi J. Inhibitory effect of Carum copticumon histamine (H1) receptors of isolated guinea pig tracheal chains. J Ethnopharmacol. 2000; 69: 217-27.
Breschi MC, Martinotti E, Catalano S, Flamini G, Morelli I, Pagni AM. Vasoconstrictor activity of 8-O-acetyl harpagide from Ajugar eptans. J Nat Prod. 1992; 55: 1145-48.
Buckle DR, Arch JR, Boering NE. Relaxation effect of potassium channel activators BRL 38227 and pinacidil on guinea pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660. Pulmon Pharmacol. 1993; 6: 77-86.
Calixto JB, Campos MM, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 2004; 70: 93-103.
Chan HJ, Lee JY, Chul HC, Chang JK. Anti-asthmatic action of quercetin and rutin in conscious guinea pigs challenged with aerosolized ovalbumin. Arch Pharm Res. 2007; 30: 1599-607.
Choo LK, Mitchelson F. Antagonism of cholinomimetics by troxypyrrolidinium in guinea pig atria and longitudinal ileal muscle: Comparison with hemicholinium-3. Eur J Pharmacol. 1978; 52: 313-22.
Chung BS, Lee HK, Kim JW. Studies on the iridoid glycoside of Ajuga spectabilis Nakai. Saengyak Hakhoechi. 1980; 11: 15-23.
Church MM, Hiroi J. Inhibition of IgE-dependant histamine release from human dispersed lung mast cells by antiallergic drugs and salbutamol. Br J Pharmacol. 1987; 90: 421–29.
Franzyk H, Jensen SR, Olsen CE. Iridoid glucoside from Myxopyrum smilacifolium. J Nat Prod. 2001; 64: 632-33.
Ge Y, Liu J, Su D. In vivo evaluation of the anti-asthmatic, antitussive and expectorant activities of extract and fractions from Elaegnus pungens leaf. J Ethnopharmacol. 2009; 126: 538-42.
Gopalakrishnan S, Rajameena R, Vadivel E. Antimicrobial activity of the leaves of Myxopyrum serratulum A. W. Hills. Int J Pharm Sci Drug Res. 2012; 4: 31-34.
Gopalakrishnan S, Rajameena R. Wound healing activity of the ethanolic of Myxopyrum serratulum A. W. Hills in rats. Int J Pharm Sci Rev Res. 2013; 27: 143-47.
Hansel TT, Tennant RC, Tan AJ, Higgins LA, Neighbour H, Erin EM, Barnes PJ. Theophylline: Mechanism of action and use in asthma and chronic obstructive pulmonary disease. Drugs Today (Barc). 2004; 40: 55-69.
Holroyde MC. The influence of epithelium on the responsiveness of guinea pig isolated trachea. Br J Pharmacol. 1986; 87: 501-07.
Hussain M, Raza S, Janbaz K. Pharmacological basis for the folkloric uses of Buxus wallichiana in gastrointestinal, respiratory and vascular disorders. Bangladesh J Pharmacol. 2015; 10: 260-66.
Janbaz K, Khan W, Saqib F, Khalid M. Pharmacological basis for the medicinal use of Viola odorata in diarrhea, bronchial asthma and hypertension. Bangladesh J Pharmacol. 2015; 10: 836-43.
Kim SH, Hong JH, Lee YC. Ursolic acid, a potential PPAR-gamma agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma. Eur J Pharmacol. 2013; 701: 131-43.
Liu W, Cheng X, Wang Y, Li S, Zheng T, Gao Y, Wang G, Qi S, Wang J, Ni J, Wang Z, Wang C. In vivo evaluation of the antitussive, expectorant and bronchodilating effect of extract and fractions from aerial parts of Peganum harmala linn. J Ethnopharmacol. 2015; 162: 79-86.
Martin CA, Naline E, Bakdach H, Advenier C. Beta3 adreno-receptor agonist, BRL37344 and SR 58611A do not induce relaxation of human, sheep and guinea pig airway smooth muscle in vitro. Eurrespir J. 1994; 7: 1610-15.
Patel MR, Bhalodia YS, Pathak NL, Patel MS, Suthar K, Patel N, Golwala DK, Jivani NP. Study on the mechanism of the bronchodilatory effects of Cynodon dactylon (Linn.) and identification of the active ingredient. J Ethnopharmacol. 2013; 150: 946-52.
Popa VT, Somani P, Simon V. The effect of inhaled verapamil on resting bronchial tone and airway constriction by histamine and acetylcholine in normal and asthmatic subjects. Am Rev Respir Dis. 1984; 130: 106-13.
Rojas A, Bah M, Rojas JI, Gutierez DM. Smooth muscle relaxing activity of gentiopicroside isolated from Gentiana spathacea. Planta Med. 2000; 66: 765-67.
Sheelarani T, Gopal V, Seethalakshmi S, Chitra K. In vitro anti-inflammatory and antiarthritic activity of selected medicinal plant. Int J Pharm Sci Rev Res. 2013; 28: 162-63.
Sheelarani T, Gopal V, Seethalakshmi S, Chitra K. In vitro antioxidant activity of Myxopyrum serratulum A. W. Hills. Int J Pharm Pharm Sci. 2013; 5: 545-46.
Sheth UK, Dadkar NK, Kamat NG. Selected topics in experimental pharmacology. 1st ed. Bombay, Kothari Book Depot, 1972, p 563.
Shi Y, Dai J, Liu H, Li RR, Sun PL, Du Pang Ll, Chen Z, Yin KS. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappa B activity in a murine model of asthma. Can J Physiol Pharmacol. 2009; 87: 729-35.
Sudharmini D, Nair AS. Antimicrobial studies of triterpenoid fractions from Myxopyrum smilacifolium Blume. Ethnobot Leaflets. 2008; 12: 912-15.
The wealth of India. A dictionary of Indian raw materials and industrial products. Vol. VI, New Delhi, CSIR, 2011, p 483.
Varughese MS, Mohammed SP, Jacob J, Devasia BN. Evaluation of anti-inflammatory and antipyretic activity of ethanolic leaves extract of Myxopyrum smilacifolium (Wall.) blume. Asian J Pharm Clin Res. 2015; 8: 212-15.
Webber S, Karlsson JA. Measurement of airway smooth muscle responsiveness in animals. Raeburn D, Giembycz MA. 3rd ed. Basel, Birkhauser-Verlag, 1996, pp 3.
Wozniak L, Skapska S, Marszalek K. Ursolic acid: A pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules 2015; 20: 20614-41.
